欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
DE/H/0309/001
药品名称
Pentastarch 6%
活性成分
poly(O-2-hydroxyethyl)starch sodium chloride 69.0 g
剂型
Solution for infusion
上市许可持有人
Baxter Deutschland GmbH Edisonstraße 4 85716 Unterschleißheim
参考成员国 - 产品名称
Germany (DE)
互认成员国 - 产品名称
Belgium (BE)
Portugal (PT)
Luxembourg (LU)
United Kingdom (Northern Ireland) (XI)
Ireland (IE)
France (FR)
Italy (IT)
许可日期
2001/11/29
最近更新日期
2024/08/19
药物ATC编码
B05AA07 hydroxyethylstarch
申请类型
TypeLevel1：
Known Active Substance
TypeLevel2：
Initial Application
TypeLevel3：
Generic Article 4.8(a)(iii), first paragraph
TypeLevel4：
Chemical Substance
TypeLevel5：
Prescription Only
附件文件下载
Final Labelling
|
labip_001_pentastarch_10_renewal_1006
Date of last change:2024/09/06
Final Labelling
|
labip_001_pentastarch_6_renewal_090227_1
Date of last change:2024/09/06
Final Labelling
|
labop_001_pentastarch_10_renewal_090227_1
Date of last change:2024/09/06
Final Labelling
|
labop_001_pentastarch_6_renewal_090227
Date of last change:2024/09/06
Final PL
|
palen_pentastarch_10_renewal_1006
Date of last change:2024/09/06
Final PL
|
palen_pentastarch_6_renewal_1006
Date of last change:2024/09/06
Final SPC
|
spcen_pentastarch_10_renewal_1006
Date of last change:2024/09/06
Final SPC
|
spcen_pentastarch_6_renewal_1006
Date of last change:2024/09/06
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase